Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease
Shulin Wei(Southwest Medical University), Xu Wu(Southwest Medical University), Li Gu(Southwest Medical University), Zhangang Xiao(Southwest Medical University), Yueshui Zhao(Southwest Medical University), Fukuan Du(Southwest Medical University), Jiayue Yang(Southwest Medical University), Xiaobing Li(Southwest Medical University), Yu Chen, Ke Wu(Southwest Medical University), Ling Xiao(Xian Yang Central Hospital), Mingxing Li(Southwest Medical University), Yu Lei(Xian Yang Central Hospital), Meijuan Chen(Southwest Medical University), Yuhong Sun(Southwest Medical University), Jing Shen(Peking University), Lishu Dong(Xian Yang Central Hospital), Wanping Li(Southwest Medical University), Qin Wang(Takeda (United States)), Shuai Deng(Southwest Medical University)
Cited by 17
Related Papers
VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
|International Journal of Biological Sciences|2022|226
NAFLD and NASH: etiology, targets and emerging therapies
|Drug Discovery Today|2024|181
Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation
|Chinese Medicine|2019|137
Chinese herbal medicines for treating ulcerative colitis via regulating gut microbiota-intestinal immunity axis
|Chinese Herbal Medicines|2023|88